文献速递腹部技术与安全CT

基于人工智能的腹部CT测量异位与正常位置脂肪预测成人死亡及心血管代谢疾病风险

AI-based abdominal CT measurements of orthotopic and ectopic fat predict mortality and cardiometabolic disease risk in adults.
PubMed 文献 · Eur Radiol · 2024-07-12

在9223例无症状成人结肠CT筛查队列中,全自动AI测量L3水平内脏脂肪面积、皮下脂肪面积、内脏/皮下脂肪比、内脏脂肪衰减、肌肉衰减及肝脏衰减,预测中位9年随访的死亡、心血管事件和糖尿病;脂肪指标预测死亡的5年AUC优于BMI,VSR>1.53、肌肉衰减<15 HU、肝脏衰减<45 HU与死亡风险升高相关。

要点

  • 脂肪指标预测死亡的5年AUC优于BMI:肌肉衰减0.721、VSR 0.661、BMI 0.499。
  • VSR>1.53死亡HR=3.1,肌肉衰减<15 HU死亡HR=5.4,肝脏衰减<45 HU死亡HR=2.3。
  • VSR>1.59心血管事件HR=2.6,VAT面积>291 cm²糖尿病HR=6.3(p<0.001)。

核心结论

  • 全自动CT腹部脂肪测量可预测无症状成人的死亡和心血管代谢疾病风险,并揭示人体测量学指标未反映的趋势。

研究设计与样本

  • 对2004年4月至2016年12月接受CT结肠筛查的无症状成人进行回顾性分析,共9223例(平均年龄57岁,男4071例、女5152例),中位随访9年,采用全自动AI工具在非增强CT上测量L3水平VAT和SAT面积、VSR、VAT衰减、肌肉衰减及肝脏衰减,参考标准为随访记录的死亡、心血管事件和糖尿病,行ROC和时间-事件分析生成AUC和按八分位分组的HR。

关键影像表现/征象

  • 腹部脂肪指标可从腹部CT非增强扫描中自动提取,包括L3水平VAT和SAT面积、VSR、VAT衰减、肌肉衰减及肝脏衰减。
  • 较高的内脏脂肪、肌肉脂肪和肝脏脂肪与死亡风险升高相关。
  • SAT与死亡风险呈U型关联,极低和极高SAT均对应更高的死亡风险。

诊断标准与关键数值

  • VSR>1.53时死亡风险HR=3.1。
  • 肌肉衰减<15 HU时死亡风险HR=5.4。
  • 肝脏衰减<45 HU时死亡风险HR=2.3。
  • VSR>1.59时心血管事件风险HR=2.6。
  • VAT面积>291 cm²时糖尿病风险HR=6.3(p<0.001)。

临床应用与阅片要点

  • 在无症状成人非增强腹部CT中,可自动测量L3水平VAT、SAT、VSR、肌肉衰减及肝脏衰减用于风险分层。
  • 脂肪指标预测死亡风险优于BMI,阅片和报告中可关注VSR>1.53、肌肉衰减<15 HU、肝脏衰减<45 HU等与死亡风险升高相关的阈值。
  • VSR>1.59与心血管事件风险升高相关,VAT面积>291 cm²与糖尿病风险升高相关(HR=6.3,p<0.001)。
  • SAT与死亡风险呈U型关联,极低和极高SAT均对应更高死亡风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the utility of CT-based abdominal fat measures for predicting the risk of death and cardiometabolic disease in an asymptomatic adult screening population.

METHODS: Fully automated AI tools quantifying abdominal adipose tissue (L3 level visceral [VAT] and subcutaneous [SAT] fat area, visceral-to-subcutaneous fat ratio [VSR], VAT attenuation), muscle attenuation (L3 level), and liver attenuation were applied to non-contrast CT scans in asymptomatic adults undergoing CT colonography (CTC). Longitudinal follow-up documented subsequent deaths, cardiovascular events, and diabetes. ROC and time-to-event analyses were performed to generate AUCs and hazard ratios (HR) binned by octile.

RESULTS: A total of 9223 adults (mean age, 57 years; 4071:5152 M:F) underwent screening CTC from April 2004 to December 2016. 549 patients died on follow-up (median, nine years). Fat measures outperformed BMI for predicting mortality risk-5-year AUCs for muscle attenuation, VSR, and BMI were 0.721, 0.661, and 0.499, respectively. Higher visceral, muscle, and liver fat were associated with increased mortality risk-VSR > 1.53, HR = 3.1; muscle attenuation < 15 HU, HR = 5.4; liver attenuation < 45 HU, HR = 2.3. Higher VAT area and VSR were associated with increased cardiovascular event and diabetes risk-VSR > 1.59, HR = 2.6 for cardiovascular event; VAT area > 291 cm2, HR = 6.3 for diabetes (p < 0.001). A U-shaped association was observed for SAT with a higher risk of death for very low and very high SAT.

CONCLUSION: Fully automated CT-based measures of abdominal fat are predictive of mortality and cardiometabolic disease risk in asymptomatic adults and uncover trends that are not reflected in anthropomorphic measures.

CLINICAL RELEVANCE STATEMENT: Fully automated CT-based measures of abdominal fat soundly outperform anthropometric measures for mortality and cardiometabolic risk prediction in asymptomatic patients.

KEY POINTS: Abdominal fat depots associated with metabolic dysregulation and cardiovascular disease can be derived from abdominal CT. Fully automated AI body composition tools can measure factors associated with increased mortality and cardiometabolic risk. CT-based abdominal fat measures uncover trends in mortality and cardiometabolic risk not captured by BMI in asymptomatic outpatients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee MH, Zea R, Garrett JW, et al. AI-based abdominal CT measurements of orthotopic and ectopic fat predict mortality and cardiometabolic disease risk in adults. Eur Radiol. 2024. PMID: 38995381. doi:10.1007/s00330-024-10935-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。